Sensitivity and Specificity of Gene Xpert in the Diagnosis of Spinal Tuberculosis: A Prospective Controlled Clinical Study
Authors:
Open Access
- 18 June 2019
- journal article
- research article
- Published by SAGE Publications in Global Spine Journal
- Vol. 10 (5) , 553-558
Abstract
Study Design: Prospective matched cohort study Objective: To evaluate the sensitivity and specificity of Gene Xpert in the diagnosis of spinal tuberculosis. Methods: From January 2016 to August 2018, Gene Xpert results were prospectively studied in 68 patients of clinicoradiologically suspected spinal tuberculosis (STB) and a control group (CG) of 92 patients, all of whom underwent computed tomography–guided/C-arm-guided/open surgical biopsy. Sensitivity, specificity, positive predictive value, and negative predictive value are obtained using standard equations. Results: Out of 68 cases of STB, Gene Xpert was positive in 62 (true positive: 62/68) and negative in 6 (false negative: 6/68). Gene Xpert was negative for all 92 cases of CG (true negative: 92/92, false positive 0/92). Thus, in our series, sensitivity of Gene Xpert is 91.18%, specificity is 100%, positive predictive value is 100%, and negative predictive value is 93.88%. Out of all cases of STB, 62/68 (91.18%) were Gene Xpert positive, but only 35/64 (54.69%) was acid-fast bacilli (AFB) culture positive and 53/60(88.33%) was histopathologically conclusive of TB. Also, Gene Xpert was positive in 7/7 (100%) cases of STB in which histopathology were inconclusive and 25/29 (86.21%) cases of STB in which AFB culture was negative. Conclusion: In STB, Gene Xpert clearly outperforms AFB culture and histopathology due to its high sensitivity and specificity apart from being rapid in diagnosis. Hence it is justified to diagnose spinal tuberculosis by Gene Xpert though histopathology is confirmative and AFB culture remains the gold standard.Keywords
This publication has 24 references indexed in Scilit:
- The role of Xpert MTB/RIF assay in the diagnosis of tubercular spondylodiscitisEuropean Spine Journal, 2017
- Diagnosis of lymph node tuberculosis using the GeneXpert MTB/RIF in TunisiaInternational Journal of Mycobacteriology, 2015
- Point‐of‐care diagnosis of tuberculosis: Past, present and futureRespirology, 2013
- Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: A meta-analysisJournal of Infection, 2012
- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyThe Lancet, 2011
- Clinical value of polymerase chain reaction in the diagnosis of joint tuberculosis by detecting the DNA ofMycobacterium tuberculosisOrthopaedic Surgery, 2011
- Tuberculosis Diagnosis — Time for a Game ChangeNew England Journal of Medicine, 2010
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceNew England Journal of Medicine, 2010
- Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidenceThe Lancet Infectious Diseases, 2003
- Genotypic Analysis of Mycobacterium tuberculosis in Two Distinct Populations Using Molecular Beacons: Implications for Rapid Susceptibility TestingAntimicrobial Agents and Chemotherapy, 2000